Ledger.Open graph →
SEC Form D · filed December 5, 2022

Acer Therapeutics Inc

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Newton, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Chris Schelling · Cambridge, MAExec · DirectorHarry S. Palmin · Newton, MAExecStephen T. Aselage · Newton, MADirectorMatthew T. Seibt · Newton, MAExecBernie S. Paul · Newton, MAExecJohn M. Dunn · Newton, MADirectorDonald R. Joseph · Newton, MAExecJohn M. Klopp · Newton, MAExecJason M. Amello · Newton, MADirectorJefferson E. Davis · Newton, MAExecAdrian S. Quartel · Newton, MAExecMichelle T. Griffin · Newton, MADirectorTanya T. Hayden · Newton, MAExecChris Schelling · Cambridge, MAExec · DirectorMatthew T. Seibt · Newton, MAExecHarry S. Palmin · Newton, MAExecBernie S. Paul · Newton, MAExecJohn M. Dunn · Newton, MADirectorDonald R. Joseph · Newton, MAExecJohn M. Klopp · Newton, MAExecStephen T. Aselage · Newton, MADirectorJason M. Amello · Newton, MADirectorJefferson E. Davis · Newton, MAExecAdrian S. Quartel · Newton, MAExecMichelle T. Griffin · Newton, MADirectorTanya T. Hayden · Newton, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗